Cell Source, Inc. (CLCS) financial statements (2020 and earlier)

Company profile

Business Address 57 WEST 57TH STREET
NEW YORK, NY 10019
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments91937171919
Cash and cash equivalents91937171919
Prepaid expense 391257275 
Deferred costs   125  
Other current assets 83613526 
Total current assets:96653233812119
Noncurrent Assets
Property, plant and equipment (3)(3)12 
Long-term investments and receivables376     
Long-term investments376     
Deferred costs   28  
Other undisclosed noncurrent assets  3   
Total noncurrent assets:376(3) 302 
Other undisclosed assets(307)3    
TOTAL ASSETS:776653236812319
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,1539532025862346
Accounts payable449278    
Accrued liabilities1,122533821115 6
Employee-related liabilities 12 12969 
Taxes payable 116147   
Interest and dividends payable5831410925  
Other undisclosed accounts payable and accrued liabilities  (875)435(735) 
Debt1,7181,4631,174708  
Deferred compensation liability651588627325  
Derivative instruments and hedges, liabilities 2016283,2802,319 
Due to related parties255222150181100 
Other liabilities 100100450  
Other undisclosed current liabilities  2,2095201,2541
Total current liabilities:4,7783,5265,0896,0503,9077
Noncurrent Liabilities
Long-term debt and lease obligation   72  
Long-term debt, excluding current maturities   72  
Liabilities, other than long-term debt   4  
Accounts payable and accrued liabilities   4  
Total noncurrent liabilities:   76  
Other undisclosed liabilities1,2141,460    
Total liabilities:5,9924,9865,0896,1263,9077
Stockholders' equity
Stockholders' equity attributable to parent, including:(5,915)(4,920)(4,557)(5,758)(3,784)11
Preferred stock  1   
Common stock26262524246
Additional paid in capital14,62811,7239,9704,7204,19136
Accumulated deficit(20,570)(16,670)(14,553)(10,503)(7,998) 
Warrants and rights outstanding    420 
Other undisclosed stockholders' equity attributable to parent11  (420)(31)
Total stockholders' equity:(5,915)(4,920)(4,557)(5,758)(3,784)11
TOTAL LIABILITIES AND EQUITY:776653236812319

Income statement (P&L) ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2015
12/31/2014
12/31/2013
Operating expenses(3,771)(2,006)(2,293)(2,320)(4,055)(26)
Other operating expense, net
(Other undisclosed Other operating expense, net)
(274)     
Other undisclosed operating income274     
Operating loss:(3,771)(2,006)(2,293)(2,320)(4,055)(26)
Nonoperating expense(404)(111)(790)(184)(3) 
Investment income, nonoperating(26)(210)    
Interest and debt expense(324)(191)(725)(36)  
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes(260)(260)48536  
Loss from continuing operations before income taxes:(4,758)(2,569)(3,323)(2,504)(4,057)(26)
Income tax expense (benefit) 717(22)6461,151 
Other undisclosed income from continuing operations717     
Loss before gain (loss) on sale of properties:(4,041)(1,852)(3,345)(1,858)(2,906)(26)
Other undisclosed net loss(365)     
Net loss:(4,407)(1,852)(3,345)(1,858)(2,906)(26)
Other undisclosed net income (loss) attributable to parent(52)(266)263(646)(1,151) 
Net loss attributable to parent:(4,459)(2,117)(3,083)(2,504)(4,057)(26)
Other undisclosed net loss available to common stockholders, basic(59)     
Net loss available to common stockholders, diluted:(4,518)(2,117)(3,083)(2,504)(4,057)(26)

Comprehensive Income ($ in thousands)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2015
12/31/2014
12/31/2013
Net loss:(4,407)(1,852)(3,345)(1,858)(2,906)(26)
Comprehensive loss, net of tax, attributable to parent:(4,407)(1,852)(3,345)(1,858)(2,906)(26)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: